Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 23.33.
Forward PE Ratio (23.33) = Close Price ($237.93) / Consensus Forward EPS ($10.20)
FORWARD PE RATIO
23.33
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+17.15%
vs the sector median at left
STERIS plc
Market Cap
$23.19B
Forward PE Ratio
23.33
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| STERIS plc (STE) | $23.19B | 23.33 |
| United Therapeutics Corporation (UTHR)vs › | $21.78B | 19.63 |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.85B | 39.38 |
| Incyte Corporation (INCY)vs › | $25.91B | 33.97 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $19.54B | 11.84 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.97B | 21.84 |
| Viatris Inc. (VTRS)vs › | $19.01B | 6.53 |
| Labcorp Holdings Inc. (LH)vs › | $27.58B | 18.35 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.19B | 29.48 |
| Medline Inc. (MDLN)vs › | $28.97B | 22.71 |
Trailing P/E
29.1
reported TTM EPS
Forward P/E
23.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.20 implies +24.7% EPS growth vs the reported trailing $8.18.
At today's $237.93 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $11.21 | $11.01 – $11.32 | 6 | 21.2x |
| 2028-03-31 | $12.25 | $12.22 – $12.27 | 6 | 19.4x |
| 2029-03-31 | $13.47 | $12.49 – $15.42 | 4 | 17.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
